Estimating the avertable disease burden and cost-effectiveness in millions saved

Andrew Mirelman, Amanda Glassman, Miriam Temin

Year of publication:	July 2016 ; Third edition
Authors:	Mirelman, Andrew ; Glassman, Amanda ; Temin, Miriam
Publisher:	Washington, DC : Center for Global Development
Subject:	Health \| Medical Care \| Medico Economic \| Cost-Effectiveness \| Program Evaluation \| Kosten-Wirksamkeits-Analyse \| Cost-effectiveness analysis \| Gesundheitskosten \| Health care costs \| Gesundheitsökonomik \| Health economics \| Krankheit \| Disease \| Wirkungsanalyse \| Impact assessment

freely available

Full text |

More access options

Check Google Scholar

In German libraries (KVK)

Which error do you want to report?

Report: URL of this record is broken

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: Addition of an URL to that resource

Please note: Sometimes more than one URL is available for a resource. Please click on "More Options" to display these URLs

Report: The language(s) of that resource is/are…

Please note: Required language not in the list? Please use comment field

Report: Addition of an identifier to that resource

Report: report typo

Report: Add statement

Report: Add keywords

Please use the commentary box to describe other errors

Would you like to receive a feedback?

Commentary

Please type the code from the image

For general questions please use this address.

Persistent link: https://www.econbiz.de/10011527383

A service of the